AMC-derived Ub, and Ub-like proteins (SUMO1, NEDD8, ISG15) (Boston Biochem) were used in fluorescence-based DUB assays to measure the activity of USP9X CD. Assays were carried out in 10-μL reaction volumes in 384-well black polypropylene PCR plates (PCR-384-BK; Axygen) and the fluorescence was measured on a Synergy plate reader (Biotek). For AMC assays, 10 nM USP9X was mixed with 0.5 μM AMC substrate in 20 mM Tris (pH 8.0), 50 mM NaCl, 0.005% Triton X-100, and 2 mM DTT, and the excitation and emission wavelengths were set at 360 and 460 nm, respectively, with a 40-nm bandwidth filter. All kinetic parameters were determined using Michaelis–Menten regression analysis in Prism 6 software (GraphPad).
Continuous diUb cleavage assays were performed using 50 nM USP9X CD and 500 nM K11- (Pos4, #UF-440; Boston Biochem) or 200 nM K63- (K63-2, #DU6302; LifeSensors) IQF-diUb substrates in an optimized USP9X buffer (20 mM Bicine, pH 8.0, 0.004% Triton X-100, 0.6 mM DTT), with excitation and emission wavelengths at 530 and 575 nm, respectively. Alternatively, for full kinetic analysis of K11 IQF-diUb and Ub-AMC substrate, 10–25 nM WT and mutant USP9X CD was used. Assays were performed in 50 mM Hepes (pH 7.8), 50 mM NaCl, 0.5 mM EDTA, 0.1 mg/mL BSA, and 1 mM DTT at 25 °C. Fluorescence was measured using a Fluoromax-4 fluorescence spectrometer (Horiba). For Ub-AMC, excitation and emission wavelengths at 355 and 440 nm were used, respectively. For IQF-diUb, excitation and emission wavelengths at 544 nm and 572 nm were used, respectively.
K11-, K48-, and K63-linked diUb-NC1-AMC2 fluorescent substrates were generated by first reacting Ub1–75-MESNA containing a respective cysteine mutation at K11, K48, or K63 with 32 mM glycine-AMC in the presence of 0.5 M MESNA, 0.17 M collidine and 5 mg/mL N-hydroxysuccinimide for 40 h. The resulting reaction mixture was treated with 10 mM DTT overnight, purified using an SP column with a salt gradient (50–500 mM NaCl) and buffer exchanged into a 20 mM MES (pH 6.5) buffer. Following purification, the cysteine-containing Ub-AMC was reacted with Ub-NC to generate diUb-NC1-AMC2 substrate (Fig. 2A) and further purified using an SP column with a salt gradient from 100 mM to 1 M NaCl. Fluorogenic assay was performed in a reaction buffer containing 50 mM Hepes (pH 7.8), 50 mM NaCl, 0.5 mM EDTA, 0.1 mg/mL BSA, and 1 mM DTT at 25 °C. Fluorescence was measured using a Fluoromax-4 fluorescence spectrometer (Horiba) with excitation and emission wavelength at 355 and 440 nm, respectively.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.